Histamine as an autocrine growth factor in experimental mammary carcinomas
- 1 November 1994
- journal article
- allergy and-histamine
- Published by Springer Nature in Inflammation Research
- Vol. 43 (1-2) , 17-20
- https://doi.org/10.1007/bf02005757
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Histamine receptors in an experimental mammary carcinomaBiomedicine & Pharmacotherapy, 1994
- Inhibition of tumor growth induced by histamine: In vivo and in vitro studiesInflammation Research, 1993
- G-protein-coupled receptors, phosphoinositide hydrolysis, and cell proliferation.1991
- The effects of histamine H2 receptor antagonists on melanogenesis and cellular proliferation in melanoma cells in cultureBiochemical and Biophysical Research Communications, 1991
- The Antiproliferative Potency of Histamine Antagonists Correlates with Inhibition of Binding of [3H]-Histamine to Novel Intracellular Receptors (HIC) in Microsomal and Nuclear Fractions of Rat LiverPublished by Springer Nature ,1991
- Role of cyclic AMP receptor proteins in growth, differentiation, and suppression of malignancy: new approaches to therapy.1990
- Pharmacology of α fluoromethylhistidine, a specific inhibitor of histidine decarboxylaseTrends in Pharmacological Sciences, 1990
- Histamine as a growth factor and chemoattractant for human carcinoma and melanoma cells: action through Ca2(+)-mobilizing H1 receptors.The Journal of cell biology, 1990
- Changes in histamine synthesis, tissue content and catabolism in human breast cancerInflammation Research, 1989
- INVOLVEMENT OF HISTAMINE IN GROWTH OF MOUSE AND RAT-TUMORS - ANTITUMORAL PROPERTIES OF MONOFLUOROMETHYLHISTIDINE, AN ENZYME-ACTIVATED IRREVERSIBLE INHIBITOR OF HISTIDINE-DECARBOXYLASE1984